Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Avadel CNS Pharmaceuticals, LLC — Rare Disease Pipeline | Kisho | Kisho
Avadel CNS Pharmaceuticals, LLC
Other
2
Orphan Designations
1
FDA Approvals
2
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
idiopathic hypersomnia
sodium oxybate
Orphan Designation
-
narcolepsy
4-((L-valyl)oxy)butanoic acid
Orphan Designation
-
← Back to Companies
